MedPath

Letoripe

Brand Name: Letoripe

Generic Name: Letrozole

Active
Registration Number

DRP-2735

Dosage Form

Tablet

Issuance Date

June 1, 2021

Expiry Date

July 9, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2.5 mg
PackagingAlu/Clear PVC Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (Rx)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LetrozoleActive
Monograph: Letrozole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform